340B Entities: Preparing for CongressionalScrutiny and Regulatory Changes
The 340B Drug Pricing Program faces mounting pressure from multiple directions as we head into fall 2025. Recent developments signal that covered entities must take proactive steps to protect their programs and prepare for potential changes. Here’s what your organization needs to know and do right now. The Current Landscape Congressional scrutiny of 340B is […]
Planning for Uncertainty: How 340B Entities Should Prepare for Impending MedicaidChanges
To say the healthcare policy landscape is fluid would be a massive understatement. Ongoing debates over federal spending, Medicaid eligibility, and safety-net funding have created unprecedented uncertainty for 340B covered entities. While the ultimate scope and timing of any changes remain unclear, prudent healthcare leaders are developing contingency plans to strengthen their organizations for whatever […]